Roche (RHHBY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec9

Roche Launches New PCR Test cobas BV/CV for Vaginal Infections

06:13

Roche's Gazyva/Gazyvaro Approved by European Commission for Lupus Nephritis Treatment

06:00

Dec8

Roche's Lunsumio® Shows Positive Progress in Lymphoma Treatment with Combination Therapy

21:30

Roche's Columvi Combination Therapy Approved in Over 50 Countries for R/R DLBCL

13:00

JPMorgan Raises Roche Holding's Rating and Price Target

04:00

Dec5

Roche Holding AG shares rose 17.46% over 30 days

01:03

Schedules & Filings

Schedules

Filings

Jan29

Earning Release(EST)

FY2025 Annual Earning Release

Jul24

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.91 B, Net Income 4.632 B, EPS 0.7212

Mar28

Distribution Plan(EST)

Cash dividend 1.3629 USD

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More